Insights

Market Access Intelligence

Timely analysis of reimbursement policy, regulatory changes, and market access strategy for medical device and SaMD innovators.

Latest
Recent Insights
01 Article
Regulatory Alert April 2026
CMS Proposes to Eliminate the Breakthrough Device NTAP Alternative Pathway

The FY 2027 Proposed Rule introduces the most consequential reimbursement policy change in years for device and SaMD innovators. Here's what it means for your market access strategy.

Read Article
Stay Informed

Have a reimbursement question?

Our team monitors policy changes so you don't have to. Reach out to discuss how the latest developments affect your product.

Talk to Our Team →